Trials / Completed
CompletedNCT02492828
Adherence of Apixaban and Warfarin in Patients With Arterial Fibrillation in Real-world Setting in Sweden
Adherence of Apixaban and Warfarin in Patients With Atrial Fibrillation in Real-world Setting in Sweden
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 41,000 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This will be a retrospective cohort study using national register linkage data (including prescription, inpatient, mortality, and socioeconomic data). The study period will be from May 29, 2013 to June 30, 2015. Patients will be followed from the start of treatment (index date) until their death, exiting the database, or until the end of the study period (June 30, 2015).
Conditions
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2016-01-01
- Completion
- 2016-01-01
- First posted
- 2015-07-09
- Last updated
- 2016-05-18
Source: ClinicalTrials.gov record NCT02492828. Inclusion in this directory is not an endorsement.